Synthetic biology company Evonetix has announced the strategic appointment of Colin McCracken as Chief Executive Officer (CEO) as the company moves ahead into the phased development and commercialisation of its semiconductor-based DNA synthesis platform. Click to read more.
/PRNewswire/ The "Flow Cytometry Markets. Forecasts by Technology. Product and Application. With Executive and Consultant Guides and including Customized.
/PRNewswire/ The "Flow Cytometry Markets. Forecasts by Technology. Product and Application. With Executive and Consultant Guides and including Customized.
Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.